Cao, Y.; Shi, . F. .; Li, Y. .; Wei, X. .; Yi, . H. .; Han, S. . Cost-Effectiveness Analysis of the Combination of Low-Dose Nivolumab With Triple Metronomic Chemotherapy for Advanced Head and Neck Squamous Cell Carcinoma in China. Health Decision 2024, 2.